Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan

Go back to Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 4.50 --0 (-0%)
Previous Close $4.50    52 Week High $45.34 
Open $4.50    52 Week Low $15.92 
Day High $4.50    P/E 1.93 
Day Low $4.50    EPS $2.33 
Volume 22